These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22035036)

  • 1. Protein-x of hepatitis B virus in interaction with CCAAT/enhancer-binding protein α (C/EBPα)--an in silico analysis approach.
    Mohamadkhani A; Shahnazari P; Minuchehr Z; Madadkar-Sobhani A; Tehrani MJ; Jazii FR; Poustchi H
    Theor Biol Med Model; 2011 Oct; 8():41. PubMed ID: 22035036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
    Wu FY; Wang SE; Chen H; Wang L; Hayward SD; Hayward GS
    J Virol; 2004 May; 78(9):4847-65. PubMed ID: 15078966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of hepatitis B viral X protein and CCAAT/ enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter.
    Choi BH; Park GT; Rho HM
    J Biol Chem; 1999 Jan; 274(5):2858-65. PubMed ID: 9915821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
    Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.
    Wu FY; Chen H; Wang SE; ApRhys CM; Liao G; Fujimuro M; Farrell CJ; Huang J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(2):1481-500. PubMed ID: 12502863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha.
    Erickson RL; Hemati N; Ross SE; MacDougald OA
    J Biol Chem; 2001 May; 276(19):16348-55. PubMed ID: 11340085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCAAT/enhancer-binding protein alpha (C/EBPalpha) activates transcription of the human microsomal epoxide hydrolase gene (EPHX1) through the interaction with DNA-bound NF-Y.
    Zhu QS; Qian B; Levy D
    J Biol Chem; 2004 Jul; 279(29):29902-10. PubMed ID: 15150264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for DNA recognition by the basic region leucine zipper transcription factor CCAAT/enhancer-binding protein alpha.
    Miller M; Shuman JD; Sebastian T; Dauter Z; Johnson PF
    J Biol Chem; 2003 Apr; 278(17):15178-84. PubMed ID: 12578822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interaction of CCAAT/enhancer-binding-protein-α basic region mutants with E2F transcription factors and DNA.
    Kowenz-Leutz E; Schuetz A; Liu Q; Knoblich M; Heinemann U; Leutz A
    Biochim Biophys Acta; 2016 Jul; 1859(7):841-7. PubMed ID: 27131901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the C/EBPα C-terminal tail residues involved in the protein interaction with GABP and their potency in myeloid differentiation of K562 cells.
    Shimokawa T; Nunomura S; Fujisawa D; Ra C
    Biochim Biophys Acta; 2013 Nov; 1829(11):1207-17. PubMed ID: 24076158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B.
    Lin SJ; Shu PY; Chang C; Ng AK; Hu CP
    J Immunol; 2003 Nov; 171(9):4708-16. PubMed ID: 14568946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cellular transcription factor, CCAAT enhancer-binding protein alpha (C/EBP-alpha), has the potential to activate the bovine herpesvirus 1 immediate-early transcription unit 1 promoter.
    Meyer F; Jones C
    J Neurovirol; 2009 Apr; 15(2):123-30. PubMed ID: 19115128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.
    Subramanian L; Benson MD; Iñiguez-Lluhí JA
    J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1).
    Wu FY; Wang SE; Tang QQ; Fujimuro M; Chiou CJ; Zheng Q; Chen H; Hayward SD; Lane MD; Hayward GS
    J Virol; 2003 Aug; 77(16):8893-914. PubMed ID: 12885907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of transcriptional activity of C/EBPalpha by E2F-dimerization partner complexes.
    Zaragoza K; Bégay V; Schuetz A; Heinemann U; Leutz A
    Mol Cell Biol; 2010 May; 30(9):2293-304. PubMed ID: 20176812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Herpesvirus saimiri replication and transcription activator acts synergistically with CCAAT enhancer binding protein alpha to activate the DNA polymerase promoter.
    Wakenshaw L; Walters MS; Whitehouse A
    J Virol; 2005 Nov; 79(21):13548-60. PubMed ID: 16227275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a co-repressor that inhibits the transcriptional and growth-arrest activities of CCAAT/enhancer-binding protein alpha.
    McFie PJ; Wang GL; Timchenko NA; Wilson HL; Hu X; Roesler WJ
    J Biol Chem; 2006 Jun; 281(26):18069-80. PubMed ID: 16644732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between regulators of myeloid development: C/EBPalpha binds and activates the promoter of the PU.1 gene.
    Kummalue T; Friedman AD
    J Leukoc Biol; 2003 Sep; 74(3):464-70. PubMed ID: 12949251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two CCAAT/enhancer binding protein sites in the cytochrome P4503A1 locus. Potential role in the glucocorticoid response.
    Rodrigues E; Vilarem MJ; Ribeiro V; Maurel P; Lechner MC
    Eur J Biochem; 2003 Feb; 270(3):556-64. PubMed ID: 12542705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.